General
Preferred name
TAURINE
Synonyms
Taurine, monopotassium salt ()
2-Aminoethanesulfonic Acid ()
Taurate ()
Ethanesulfonic acid, 2-amino- ()
O-Due ()
NSC-32428 ()
FEMA NO. 3813 ()
Aminoethylsulfonic Acid ()
Taurine-d4 ()
P&D ID
PD000392
CAS
342611-14-7
107-35-7
Tags
natural product
drug
available
Approved by
PMDA
FDA
First approval
2019
Drug Status
nutraceutical
approved
Drug indication
Discovery agent
Max Phase
Phase 4
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Endogenous potentiator of NMDA receptors
(Tocris Bioactive Compound Library)
DESCRIPTION
Non-selective endogenous agonist at glycine receptors
(LOPAC library)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
25
AdooQ Bioactive Compound Library
ChEMBL Approved Drugs
ChEMBL Drugs
Concise Guide to Pharmacology 2017/18
Concise Guide to Pharmacology 2019/20
Concise Guide to Pharmacology 2021/22
Concise Guide to Pharmacology 2023/24
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMatrix
Enamine BioReference Compounds
Guide to Pharmacology
LOPAC library
MedChem Express Bioactive Compound Library
NPC Screening Collection
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
The Spectrum Collection
Tocris Bioactive Compound Library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
54
Properties
(calculated by RDKit )
Molecular Weight
125.01
Hydrogen Bond Acceptors
3
Hydrogen Bond Donors
2
Rotatable Bonds
2
Ring Count
0
Aromatic Ring Count
0
cLogP
-1.17
TPSA
80.39
Fraction CSP3
1.0
Chiral centers
0.0
Largest ring
0.0
QED
0.46
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Pathway
Metabolism
Autophagy
Metabolic Enzyme/Protease
Target
LDL
VLDL
Endogenous Metabolite
Primary Target
Glycine Receptors
MOA
Agonist
Antioxidant
Indication
anxiety, irritability, sleeplessness
Source data